$53.62
-0.15 (-0.28%)
Covance, Inc. (CVD)
CAPS Rating:
A drug development services company providing a range of early stage and late stage product development services on a worldwide basis primarily to the pharmaceutical, biotechnology and medical device industries.

RSS Headlines
Fool UK